Keyword: Pfizer

News

Drug Patent Losses Worth Billions Seen in 2017

03.05.2017 - Major pharmaceutical producers threaten to lose $26.5 billion in annual sales this year, as 18 branded drugs are due to expire, analysts for investment bank Bernstein said in a...

News

Pharma Chiefs Call for Decision on EMA

25.04.2017 - Pharma chiefs are urging European heads of state to decide sooner rather than later on the new location for the European Medicines Agency (EMA), which is due to leave the UK as a...

News

Death Penalty Drugs Under Scrutiny Again

21.04.2017 - As a debate rages over plans by the US state of Arkansas to execute eight death row inmates before its supply of lethal drugs expires at the end of April, the international...

News

Pfizer CEO Criticizes US Healthcare

27.03.2017 - On the eve of the US Republican party’s failed bid to repeal the Affordable Care Act (AHA) of former US president, Barack Obama and replace it with its own plan, Pfizer CEO Ian...

News

Pfizer Said Looking for Gene Therapy Site

13.03.2017 - After acquiring the remaining stake in Bamboo Therapeutics, a privately held gene therapy group based in Chapel Hill, North Carolina, USA, last year in a drive to be a major player...

News

Concordia and Actavis UK Accused of Overpricing

09.03.2017 - The UK’s Competition and Markets Authority (CMA) has accused Concordia and Actavis UK of breaking competition law by agreeing to delay competition and keeping the price of...

News

FDA Accepts Merck-Pfizer Biologics Application

01.03.2017 - In the course of only a week, the US Food and Drug Administration FDA) has accepted the second Biologics License Application (BLA) for priority review. In the latest case, the...

News

US Drugmakers Urge Tax Code Reform

24.02.2017 - In a letter to the leadership of the US Congress, 16 CEOs of major American companies, including Pfizer’s Ian Read, Eli Lilly’s David Ricks, Merck & Co’s Ken Frazier and Celgene’s...